Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
5.825 USD | +3.83% | +10.61% | +13.18% |
May. 02 | Earnings Flash (SGHT) SIGHT SCIENCES Reports Q1 Revenue $19.3M, vs. Street Est of $18.4M | MT |
May. 02 | Transcript : Sight Sciences, Inc., Q1 2024 Earnings Call, May 02, 2024 |
Strengths
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- Growth remains a strong point in this company. In their sales forecast, analysts sound optimistic with regard to sales prospects.
- The average price target of analysts who are interested in the stock has been strongly revised upwards over the last four months.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- For the last 12 months, analysts have been regularly downgrading their EPS expectations. Analysts predict worse results for the company against their predictions a year ago.
- Over the past twelve months, analysts' consensus has been significantly revised downwards.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+13.18% | 279M | C- | ||
-4.02% | 184B | C+ | ||
-1.32% | 107B | C | ||
-3.40% | 69.44B | A | ||
+3.12% | 50.37B | B- | ||
+8.52% | 44.82B | B- | ||
+3.40% | 41.53B | B+ | ||
+3.02% | 26.84B | A- | ||
+3.93% | 26.73B | B | ||
+15.23% | 25.71B | A- |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock Market
- Equities
- SGHT Stock
- Ratings Sight Sciences, Inc.